- Home
- TNYA vs JHI Comparison
TNYA vs JHI Comparison
Compare TNYA & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- JHI
- Stock Information
- Founded
- TNYA 2016
- JHI 1971
- Country
- TNYA United States
- JHI United States
- Employees
- TNYA N/A
- JHI N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- JHI Trusts Except Educational Religious and Charitable
- Sector
- TNYA Health Care
- JHI Finance
- Exchange
- TNYA Nasdaq
- JHI Nasdaq
- Market Cap
- TNYA 119.2M
- JHI 124.3M
- IPO Year
- TNYA 2021
- JHI N/A
- Fundamental
- Price
- TNYA $1.43
- JHI $14.01
- Analyst Decision
- TNYA Strong Buy
- JHI
- Analyst Count
- TNYA 4
- JHI 0
- Target Price
- TNYA $17.33
- JHI N/A
- AVG Volume (30 Days)
- TNYA 6.3M
- JHI 29.5K
- Earning Date
- TNYA 11-06-2024
- JHI 01-01-0001
- Dividend Yield
- TNYA N/A
- JHI 6.80%
- EPS Growth
- TNYA N/A
- JHI N/A
- EPS
- TNYA N/A
- JHI 1.05
- Revenue
- TNYA N/A
- JHI N/A
- Revenue This Year
- TNYA N/A
- JHI N/A
- Revenue Next Year
- TNYA N/A
- JHI N/A
- P/E Ratio
- TNYA N/A
- JHI $12.47
- Revenue Growth
- TNYA N/A
- JHI N/A
- 52 Week Low
- TNYA $0.99
- JHI $11.63
- 52 Week High
- TNYA $7.01
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- TNYA 37.10
- JHI 54.77
- Support Level
- TNYA $1.33
- JHI $13.84
- Resistance Level
- TNYA $1.63
- JHI $13.89
- Average True Range (ATR)
- TNYA 0.15
- JHI 0.10
- MACD
- TNYA 0.01
- JHI 0.03
- Stochastic Oscillator
- TNYA 18.92
- JHI 95.64
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.